Akorn

Shuttered Akorn recalls all its After shutting down, Akorn recalls its 70-plus products nationwidepharmaceuticals
BioSpace
Thu, 04/27/23 - 10:52 pm
Akorn
recalls
bankruptcy
Akorn's downfall amplifies shortage of asthma med albuterol, FDA warns
Fierce Pharma
Thu, 03/9/23 - 10:18 pm
Akorn
drug shortages
albuterol
FDA
6 pharmaceutical, devicemaker bankruptcies in 2020
Beckers Hospital Review
Tue, 06/23/20 - 11:44 pm
bankruptcy
devices
pharma industry
KRS Global
Insys
Valeritas
Reva Medical
Akorn
Mallinckrodt
Generic drugmaker Akorn files for bankruptcy
Beckers Hospital Review
Thu, 05/21/20 - 10:22 am
Akorn
generics
bankruptcy
After Fresenius deal collapse, Akorn inks $74M settlement with investors over data integrity woes
Fierce Pharma
Fri, 08/2/19 - 12:13 am
Akorn
Fresenius
Teetering Akorn hit with another FDA warning letter
Fierce Pharma
Tue, 06/25/19 - 07:17 pm
Akorn
generics
FDA
warning letters
Here's Why Akorn Stock Rose as Much as 14.4% Today
Motley Fool
Mon, 04/22/19 - 03:17 pm
Akorn
FDA
generics
Flonase
Alrex
Lotemax
Akorn Inc. Scores Two Generic Approvals from the FDA
BioSpace
Fri, 04/19/19 - 10:40 am
Akorn
FDA
generics
Flonase
GSK
Lotemax
Bausch + Lomb
Fresenius moves forward with two U.S. expansions after killing Akorn deal
Fierce Pharma
Wed, 04/10/19 - 10:58 am
Fresenius Kabi
Akorn
drug manufacturing
Akorn's drug pipeline 'held hostage' with FDA warning letter
BioPharma Dive
Thu, 01/10/19 - 08:39 pm
Akorn
FDA
warning letter
drug manufacturing
Akorn's CEO bows out after failing last-ditch bid to save Fresenius merger
Fierce Pharma
Mon, 12/10/18 - 07:02 pm
Akorn
Fresenius
M&A
Fentanyl Billionaire No More: John Kapoor's Net Worth Drops Below $1 Billion
Forbes
Sat, 12/8/18 - 11:00 am
INSYS Therapeutics
John Kapoor
Fentanyl
Akorn
Akorn fights to salvage Fresenius deal in appeal to Delaware Supreme Court
Fierce Pharma
Thu, 12/6/18 - 12:59 pm
Akorn
Fresenius
M&A
Judge frees Fresenius from buyout, citing 'extensive and recurring' data problems at Akorn
Fierce Pharma
Mon, 10/1/18 - 02:31 pm
Akorn
Fresenius
M&A
Fresenius SE Walks Away from $4.3 Billion Takeover of Akorn
CP Wire
Sun, 04/22/18 - 11:18 pm
Fresenius SE
Akorn
M&A
Fresenius SE Walks Away from $4.3 Billion Takeover of Akorn
Sun, 04/22/18 - 11:15 pm
Fresenius SE
Akorn
M&A
Fresenius' $4.3B buyout of Akorn threatened by data integrity probe
Fierce Pharma
Tue, 02/27/18 - 11:33 am
Fresenius
Akorn
drug manufacturing
generics
data integrity
FDA
Allergan heads to federal court to defend Restasis against early generic rivals
Fierce Pharma
Tue, 08/29/17 - 09:14 pm
Allergan
Restasis
generics
Mylan Labs
Teva Pharmaceutical
Akorn
InnoPharma
How Trump’s First 100 Days Affected the Healthcare Industry
Motley Fool
Tue, 05/2/17 - 10:10 am
Donald Trump
Express Scripts
Anthem
insurers
Akorn
Fresenius
Fresenius Kabi picks up generic maker Akorn for $4.3B
BioPharma Dive
Tue, 04/25/17 - 11:22 am
M&A
generics
Fresenius
Akorn

Pages